Multidisciplinary Practical Guidance for Implementing Adjuvant CDK4/6 Inhibitors for Patients with HR-Positive, HER2-Negative Early Breast Cancer in Canada.
Saved in:
| Title: | Multidisciplinary Practical Guidance for Implementing Adjuvant CDK4/6 Inhibitors for Patients with HR-Positive, HER2-Negative Early Breast Cancer in Canada. |
|---|---|
| Authors: | Jerzak, Katarzyna J.1 (AUTHOR) katarzyna.jerzak@sunnybrook.ca, Sehdev, Sandeep2 (AUTHOR), Boileau, Jean-François3 (AUTHOR), Brezden-Masley, Christine4 (AUTHOR), Califaretti, Nadia5 (AUTHOR), Edwards, Scott6 (AUTHOR), Gordon, Jenn7 (AUTHOR), Henning, Jan-Willem8 (AUTHOR), LeVasseur, Nathalie9 (AUTHOR), Railton, Cindy8 (AUTHOR) |
| Source: | Current Oncology. Aug2025, Vol. 32 Issue 8, p444. 19p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 11980052 |
|---|---|
| DOI: | 10.3390/curroncol32080444 |
